Both in Pharmaceuticals
TuHURA Biosciences vs Atrium Therapeutics
Over the past year HURA returned −9.7% and RNA returned −83.7%; their daily moves had a correlation of 0.04.
HURA −9.7% RNA −83.7%Growth of $1, one year, split-adjusted
| Metric | HURA | RNA |
|---|---|---|
| Price | $2.09 | $8.00 |
| Market cap | $132.9M | $136.8M |
| Today | +18.47% | +0.25% |
| 1 month | −2.1% | −13.2% |
| 6 months | −22.2% | −41.4% |
| Year to date | +175.5% | −88.9% |
| 1 year | −14.9% | — |
| Revenue growth (YoY) | — | −21.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −672.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.8× |
| Net cash | -$4.2M | $263.9M |
| Dividend yield | — | — |
| Volatility (60d) | 67.0% | 65.6% |
| Short % of float | 13.7% | 20.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).